A randomized, triple-arm study to compare the viral and immunological outcome of HAART during 6 versus 15 months versus no treatment in patients with primary HIV 1 infection.
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 173
Inclusion Criteria
Diagnosis of acute/ recent HIV-1 infection: plasma HIV-1 RNA load detectable and/or detectable serum p24 antigen and one of the following:
1. ELISA: HIV-1 specific antibodies negative;
Exclusion Criteria
1. Previous test result with HIV-1 RNA detectable or P24 antigen positive > 180 days before presentation;
2. For female subjects: pregnancy (positive urine pregnancy test) or breast feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method